Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
25.09
+0.06 (0.24%)
At close: Dec 26, 2025, 4:00 PM EST
25.08
-0.01 (-0.04%)
Pre-market: Dec 29, 2025, 5:15 AM EST
Pfizer Stock Forecast
Stock Price Forecast
The 10 analysts that cover Pfizer stock have a consensus rating of "Hold" and an average price target of $27.4, which forecasts a 9.21% increase in the stock price over the next year. The lowest target is $24 and the highest is $35.
Price Target: $27.4 (+9.21%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Pfizer stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 3 | 2 | 2 | 1 | 0 | 0 |
| Hold | 9 | 8 | 8 | 8 | 7 | 9 |
| Sell | 1 | 1 | 1 | 1 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 13 | 13 | 12 | 9 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $28 → $27 | Hold | Maintains | $28 → $27 | +7.61% | Dec 17, 2025 |
| B of A Securities | B of A Securities | Hold Maintains $29 → $28 | Hold | Maintains | $29 → $28 | +11.60% | Dec 15, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $32 → $28 | Hold | Maintains | $32 → $28 | +11.60% | Dec 12, 2025 |
| Citigroup | Citigroup | Hold Initiates $26 | Hold | Initiates | $26 | +3.63% | Dec 2, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $33 → $35 | Strong Buy | Maintains | $33 → $35 | +39.50% | Nov 24, 2025 |
Financial Forecast
Revenue This Year
62.83B
from 63.63B
Decreased by -1.26%
Revenue Next Year
61.75B
from 62.83B
Decreased by -1.70%
EPS This Year
3.15
from 1.41
Increased by 123.21%
EPS Next Year
3.04
from 3.15
Decreased by -3.61%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 66.6B | 65.9B | ||||
| Avg | 62.8B | 61.8B | ||||
| Low | 59.9B | 58.2B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 4.7% | 4.9% | ||||
| Avg | -1.3% | -1.7% | ||||
| Low | -5.8% | -7.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 3.40 | 3.47 | ||||
| Avg | 3.15 | 3.04 | ||||
| Low | 2.94 | 2.74 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 140.9% | 9.9% | ||||
| Avg | 123.2% | -3.6% | ||||
| Low | 108.2% | -12.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.